索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]窦鸿伟,汤学超,秦永文.左心耳封堵术后血栓及栓塞事件[J].国际心血管病杂志,2018,01:16-19.
点击复制

左心耳封堵术后血栓及栓塞事件(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2018年01期
页码:
16-19
栏目:
综述
出版日期:
2018-01-25

文章信息/Info

Title:
-
作者:
窦鸿伟; 汤学超; 秦永文
200433 上海,中国人民解放军海军军医大学附属长海医院
Author(s):
-
关键词:
心房颤动;  左心耳封堵术;  栓塞;  器械相关血栓
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-534X.2018.01.005
文献标识码:
-
摘要:
左心耳封堵术是降低心房颤动患者血栓栓塞风险的有效替代治疗方法。虽然左心耳封堵术经过多年临床应用已较为成熟,但仍有封堵器栓塞、器械相关血栓形成及血栓栓塞等不良事件发生。该文介绍了近年来有关左心耳封堵术后血栓及栓塞事件的相关研究。
Abstract:
-

参考文献/References

[1] 陈伟伟, 高润霖, 刘力生, 等. 《中国心血管病报告2014》概要[J]. 中国循环杂志, 2015, 31(7):617-622.
[2] 刘毅, 王琼, 陶凌. 左心耳封堵术:目前指南解读[J]. 心脏杂志, 2017, 29(1):1-3.
[3] Friberg L, Rosenqvist M, Lindgren A, et al. High prevalence of atrial fibrillation among patients with ischemic stroke[J]. Stroke, 2014, 45(9):2599-2605.
[4] Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology(ESC)[J]. Europace, 2010, 12(10):1360-1420.
[5] Alipour A, Wintgens LI, Swaans MJ, et al. Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device[J]. Vasc Health Risk Manag, 2017, 13:81-90.
[6] 郭雪原, 马长生. 左心耳封堵策略选择[J]. 心脏杂志, 2017, 29(1):4-6.
[7] 苏晞. 左心耳封堵治疗的最新研究进展[J]. 实用医院临床杂志, 2017, 14(1):9-12.
[8] Saw J, Kar S, Price MJ. Left atrial appendage closure[M/OL]. Switzerland: Springer, 2016:144-168.
[9] Bajaj NS, Parashar A, Agarwal SA, et al. Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation a systematic review and analysis of observational studies[J]. JACC Cardiovasc Interv, 2014, 7(3):296-304.
[10] Aminian A, Lalmand J, Tzikas A, et al. Embolization of left atrial appendage closure devices: a systematic review of cases reported with the watchman device and the amplatzer cardiac plug[J]. Catheter Cardiovasc Interv, 2015, 86(1):128-135.
[11] Saw J, Fahmy P, Dejong P, et al. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure[J]. Eur Heart J Cardiovasc Imaging, 2015, 16(11):1198-1206.
[12] Fahmy P, Eng L, Saw J. Retrieval of embolized left atrial appendage devices[J]. Catheter Cardiovasc Interv, 2016, Sep 28.[Epub ahead of print].
[13] Tiyerili V, Nickenig G, Hammerstingl C. Catch of the day: interventional device retrieval after late embolization of an Amplatzer cardiac plug left atrial appendage occluder[J]. Clin Res Cardiol, 2015, 104(12):1106-1108.
[14] Schroeter MR, Danner BC, Hünlich M, et al. Uncommon delayed and late complications after percutaneous left atrial appendage closure with Amplatzer(○R)cardiac plug[J]. Clin Res Cardiol, 2014, 103(4):285-290.
[15] 马长生, 杜昕, 董建增, 等. 应用Amplatzer装置行经皮左心耳堵闭术一例报告[J]. 中国介入心脏病学杂志, 2004, 12(4):254-255.
[16] 许莘浙, 朱霞, 陈莎莉. 1例经皮导管左心耳封堵术术中封堵器脱落的手术配合[J]. 全科护理, 2017, 15(4):501-503.
[17] Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial[J]. Lancet, 2009, 374(9689):534-542.
[18] Belgaid DR, Khan Z, Zaidi M, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial[J]. Int J Cardiol, 2016, 219:177-179.
[19] Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman left atrial appendage system for embolic protection in patients with AF(PROTECT AF)clinical trial and the continued access registry[J]. Circulation, 2011, 123(4):417-424.
[20] Reddy VY, M?bius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study(ASA plavix feasibility study with watchman left atrial appendage closure technology)[J]. J Am Coll Cardiol, 2013, 61(25):2551-2556.
[21] Plicht B, Konorza TF, Kahlert P, et al. Risk factors for thrombus formation on the Amplatzer cardiac plug after left atrial appendage occlusion[J]. JACC Cardiovasc Interv, 2013, 6(6):606-613.
[22] Lammers J, Elenbaas T, Meijer A. Thrombus formation on an Amplatzer closure device after left atrial appendage closure[J]. Eur Heart J, 2013, 34(10):741.
[23] Main ML, Fan DL, Reddy VY, et al. Assessment of device-related thrombus and associated clinical outcomes with the Watchman left atrial appendage closure device for embolic protection in patients with atrial fibrillation(from the PROTECT-AF trial)[J]. Am J Cardiol, 2016, 117(7):1127-1134.
[24] Ketterer U, D’Ancona G, Siegel I, et al. Percutaneous left atrial appendage occlusion: device thrombosis in clopidogrel non-responders[J]. Int J Cardiol, 2016, 204:196-197.
[25] Huang WP, Zhang YH, He L, et al. Efficacy and safety of the Watchman left atrial appendage system for stroke prevention in Chinese patients with nonvalvular atrial fibrillation: a single-center, prospective, observational study[J]. Chin Med J(Engl), 2017, 130(4):434-438.
[26] López Mínguez JR, Asensio JM, Gragera JE, et al. Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure[J]. Heart, 2015, 101(11):877-883.
[27] Saw J, Tzikas A, Shakir S, et al. Incidence and clinical impact of device-associated thrombus and peri-device leak following left atrial appendage closure with the Amplatzer cardiac plug[J]. JACC Cardiovasc Interv, 2017, 10(4):391-399.
[28] Lempereur M, Aminian A, Freixa X, et al. Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer cardiac plug and the Amulet[J]. Catheter Cardiovasc Interv, 2017, 90(5):E111-E121.
[29] Ledwoch J, Franke J, Gonzaga M, et al. Left atrial appendage closure: first in man with the 4th generation Watchman device[J]. Catheter Cardiovasc Interv, 2016, 87(4):787-794.
[30] Cruz-Gonzalez I, Martín Moreiras J, García E. Thrombus formation after left atrial appendage exclusion using an Amplatzer cardiac plug device[J]. Catheter Cardiovasc Interv, 2011, 78(6):970-973.
[31] Chowdhury MA, Elabbassi W, Al Nooryani A. Left atrial appendage occlusion device-related thrombus: a case report and review of the literature[J]. J Echocardiogr, 2012, 10(2):65-66.
[32] Qazi AH, Wimmer AP, Huber KC, et al. Resolution(and late recurrence)of Watchman device-related thrombus following treatment with dabigatran[J]. Echocardiography, 2016, 33(5):792-795.
[33] Wallenborn J, Weidemann F, Lengenfelder BA, et al. Thrombus-in-transit following Watchman device implantation[J]. Echocardiography, 2016, 33(5):788-791.
[34] Lam SC, Bertog S, Sievert H. Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second-generation Amplatzer cardiac plug(Amulet device)[J]. Catheter Cardiovasc Interv, 2015, 85(2):321-327.
[35] Shamim S, Magalski A, Chhatriwalla AK, et al. Transesophageal echocardiographic diagnosis of a Watchman left atrial appendage closure device thrombus 10 years following implantation[J]. Echocardiography, 2017, 34(1):128-130.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81670342)通信作者:秦永文,Email:chqinyw@163.com
更新日期/Last Update: 2018-04-01